 | Alpine Immune Sciences up 8% premarket on encouraging data on lead candidate
seekingalpha.com - January 24 at 4:31 PM |
 | Alpine Immune Sciences Presents New Preclinical Data at 2020 Crohn’s & Colitis Congress
ALPN-101 demonstrates efficacy in treatment of chronic inflammatory bowel disease in both in vivo and in vitro models
finance.yahoo.com - January 24 at 8:49 AM |
 | Critical Review: Alpine Immune Sciences (NASDAQ:ALPN) versus Advanz Pharma (NASDAQ:CXRXF)
www.americanbankingnews.com - January 17 at 9:46 PM |
| Brokerages Expect Alpine Immune Sciences Inc (NASDAQ:ALPN) Will Announce Quarterly Sales of $280,000.00
www.americanbankingnews.com - January 15 at 3:32 AM |
| Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares This Year?
finance.yahoo.com - January 14 at 8:19 AM |
| Zacks: Brokerages Expect Alpine Immune Sciences Inc (NASDAQ:ALPN) Will Post Earnings of -$0.55 Per Share
www.americanbankingnews.com - January 13 at 2:34 PM |
| Alpine Immune Sciences Announces Poster Presentation at 2020 Crohn’s & Colitis Congress
finance.yahoo.com - January 6 at 9:53 AM |
| Is Alpine Immune Sciences, Inc. (ALPN) A Good Stock To Buy?
finance.yahoo.com - December 22 at 5:20 PM |
| Alpine Immune Sciences Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at the 61st American Society of Hematology Annual Meeting
finance.yahoo.com - December 9 at 8:37 AM |
| Alpine Immune Sciences to Participate in Fireside Chat at 31st Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 26 at 10:32 AM |
| Alpine Immune Sciences, Inc. (ALPN) CEO Mitchell Gold on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 14 at 12:59 AM |
| Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 13 at 7:58 PM |
| Alpine Immune Sciences Presents New ALPN-101 Preclinical Data at the 2019 American College of Rheumatology (ACR) Annual Meeting
finance.yahoo.com - November 12 at 12:29 PM |
| Alpine Immune Sciences Presents New Preclinical Data at The Society for Immunotherapy of Cancer's (SITC) 34th Annual Meeting
finance.yahoo.com - November 8 at 8:23 AM |
| Alpine Immune Sciences Announces Oral Presentation of ALPN-101 at the 61st American Society of Hematology Annual Meeting and Exposition
finance.yahoo.com - November 6 at 1:28 PM |
| Alpine Immune Sciences Completes Enrollment of Phase I Study of ALPN-101 and Announces Third Quarter Conference Call
finance.yahoo.com - October 30 at 8:58 AM |
| Do Institutions Own Shares In Alpine Immune Sciences, Inc. (NASDAQ:ALPN)?
finance.yahoo.com - October 20 at 2:11 PM |
| Alpine Immune Sciences Announces Upcoming Scientific Presentations at SITC and ACR/ARHP 2019 Annual Meetings
finance.yahoo.com - October 2 at 9:21 AM |
| Alpine Immune Sciences to Present at 2019 Ladenburg Thalmann Healthcare Conference
finance.yahoo.com - September 18 at 3:27 AM |
| Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?
finance.yahoo.com - August 21 at 7:41 PM |
| Alpine Immune Sciences Provides Pipeline Update and Reports Second Quarter 2019 Financial Results
finance.yahoo.com - August 13 at 10:34 AM |
| Investors Who Bought Alpine Immune Sciences (NASDAQ:ALPN) Shares A Year Ago Are Now Down 43%
finance.yahoo.com - June 23 at 5:24 PM |
| Introducing Alpine Immune Sciences (NASDAQ:ALPN), The Stock That Dropped 43% In The Last Year
finance.yahoo.com - June 23 at 5:24 PM |
| Alpine Immune Sciences Appoints Biopharma Veteran Wayne Gombotz as Chief Technology Officer
finance.yahoo.com - June 3 at 9:27 AM |
| Alpine Immune Sciences to Present at Upcoming Investor Conferences
finance.yahoo.com - May 24 at 9:38 AM |
| AdaptImmune partners to advance promising cancer immunotherapies
finance.yahoo.com - May 15 at 6:47 PM |
| Alpine Immune Sciences misses by $0.01
seekingalpha.com - May 9 at 9:32 AM |
| Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to Decline
finance.yahoo.com - May 6 at 6:29 PM |
| Have Insiders Been Buying Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Shares?
finance.yahoo.com - April 24 at 5:34 PM |
| Alpine Immune Sciences Appoints Stanford Peng to President and Head of Research and Development
finance.yahoo.com - April 18 at 9:48 AM |
| The Zacks Analyst Blog Highlights: CMS Energy, Alpine Immune Sciences, Kohl's, Franklin Resources and Dominion Energy
finance.yahoo.com - April 11 at 6:27 PM |
| Will Nivalis Therapeutics Continue to Surge Higher?
finance.yahoo.com - April 5 at 8:54 AM |
 | Alpine Immune Sciences Inc
www.bloomberg.com - March 19 at 9:50 AM |
| Alpine Immune Sciences Provides Corporate Update and Reports Full Year 2018 Financial Results
finance.yahoo.com - March 18 at 9:18 AM |
| Alpine Immune Sciences: A New Name On The Radar
seekingalpha.com - March 8 at 6:29 PM |
| Alpine Immune Sciences Presents Preclinical ALPN-101 GvHD Data at the 2019 Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR (TCT Meetings)
finance.yahoo.com - February 19 at 9:55 AM |
| Alpine Immune Sciences Announces First Subjects Dosed in Phase I Clinical Trial for Lead Autoimmune/Inflammatory Disease Program ALPN-101
finance.yahoo.com - February 11 at 10:56 AM |
 | Alpine Immune Sciences Inc.
www.barrons.com - January 23 at 5:30 PM |
| Alpine Immune raises $25M via private placement
seekingalpha.com - January 16 at 9:25 AM |
| Alpine Immune Sciences Announces $25 Million Private Placement
finance.yahoo.com - January 16 at 9:25 AM |
| Angion Completes Equity Financing and Appoints Senior Executives
finance.yahoo.com - January 4 at 4:57 PM |
